In Canada, lung cancer remains the leading cause of cancer-related deaths, yet it remains one of the most underfunded in terms of research. To address this major issue, the Cancer Research Society aims to invest at least $2 million in translational research on this disease.
This competition will fund at least 4 translational research projects that will contribute to:
Official results will be announced shortly.
This major investment was made possible by the exceptional generosity of donors, including the Fondation Famille Gosselin, The Molson Foundation, and the George Papadopoulos Memorial Fund. It reflects a deep commitment to research and innovation, with the hope of offering a brighter future to those affected.
Forms will be available once a funding decision has been made.
